Attributes | Values |
---|
rdf:type
| |
Description
| - Acyclic nucleoside phosphonate 9-[2-hydroxy-3-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) augments production of nitric oxide by macrophages and stimulates secretion of cytokines and chemokines implied in replication and/or penetration of HIV in cells. The N6-derivatives were biologically less active or inactive.
- Acyclic nucleoside phosphonate 9-[2-hydroxy-3-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) augments production of nitric oxide by macrophages and stimulates secretion of cytokines and chemokines implied in replication and/or penetration of HIV in cells. The N6-derivatives were biologically less active or inactive. (en)
- Acyklický nukleosidfosfonáf 9-[2-hydroxy-3-(fosfonometoxy)propyl]-2,6-diaminopurin (HPMPDAP) zvyšuje u makrofágů produkci oxidu dusnatého a stimuluje sekreci cytokinů, které interferují s replikací nebo průnikem viru HIV do buněk. Deriváty substituované v pozici N6 byly biologicky méně aktivní nebo neaktivní. (cs)
|
Title
| - Nucleotide analogues with immunobiological properties: 9-[2-hydroxy-3-(phosphonomethoxy)propyl]adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives
- Analogy nukleotidů s imunobiologickými vlastnostmi: 9-[2-hydroxy-3-(fosfonometoxy)propyl]adenin (HPMPA), -2,6-diaminopurin (HPMPDAP), a jejich N6-substituované deriváty (cs)
- Nucleotide analogues with immunobiological properties: 9-[2-hydroxy-3-(phosphonomethoxy)propyl]adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives (en)
|
skos:prefLabel
| - Nucleotide analogues with immunobiological properties: 9-[2-hydroxy-3-(phosphonomethoxy)propyl]adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives
- Analogy nukleotidů s imunobiologickými vlastnostmi: 9-[2-hydroxy-3-(fosfonometoxy)propyl]adenin (HPMPA), -2,6-diaminopurin (HPMPDAP), a jejich N6-substituované deriváty (cs)
- Nucleotide analogues with immunobiological properties: 9-[2-hydroxy-3-(phosphonomethoxy)propyl]adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives (en)
|
skos:notation
| - RIV/68378041:_____/06:00043783!RIV07-AV0-68378041
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(1M0508), P(GA305/03/1470), Z(AV0Z40550506), Z(AV0Z50390512)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68378041:_____/06:00043783
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Acyclic nucleotide analogues; HPMPA 9-[2-hydroxy-3-(phosphonomethoxy)propyl]adenine (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - European Journal of Pharmacology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Holý, Antonín
- Krečmerová, Marcela
- Zídek, Zdeněk
- Kmoníčková, Eva
- Potměšil, Petr
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
is http://linked.open...avai/riv/vysledek
of | |